Lipopolysaccharides, from S. enterica serotype minnesota Re 595 (Re mutant)
Lipopolysaccharides (LPS), from S. enterica (Salmonella enterica) serotype minnesota Re 595 (Re mutant) is prepared from Salmonella enterica strain Re 595 (Re mutant) . The structure in the LPS of strain Re 595 was shown to induce secretion and aggregation in human platelets[1]. It is recommended to prepare a solution with concentration ≥2 mg/mL. Vortex thoroughly for more than 10 minutes. Due to the adsorption characteristics of LPS, silanized container or low adsorption centrifuge tubes should be used for aliquoting and storage, and mix thoroughly before use.
Product Specifications
Product Name Alternative
LPS, from Salmonella enterica (Serotype minnesota Re 595 (Re mutant) )
UNSPSC
12352200
Target
Bacterial; Toll-like Receptor (TLR)
Related Pathways
Anti-infection; Immunology/Inflammation
Field of Research
Inflammation/Immunology
Smiles
[Lipopolysaccharides,fromS.entericaserotypeminnesotaRe595(Remutant)]
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Explore Other Products
Browse additional items from our catalog